Clinical Practice
ProlivRx for Depression: At-Home Neuromodulation PMHNPs Should Know
ProlivRx is the first FDA-approved at-home neuromodulation for treatment-resistant depression. Here's what PMHNPs need to know about prescribing it.
Tagged
FDA
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Clinical Practice
FDA ADHD Stimulant Label Change: Weight Loss Risk PMHNPs Must Know
The FDA now requires weight loss warnings on all extended-release ADHD stimulants for patients under 6. Here's what PMHNPs need to know about monitoring, documentation, and the 10% weight percentile threshold.